SITAVIG®

SITAVIG® 50 mg, muco‐adhesive buccal tablets.

SITAVIG® is a single dose tablet indicated for the treatment of recurrent herpes labialis in immunocompetent adults with frequent herpes episodes.

Summary of product characteristics and patient leaflet will be available here: http://base-donnees-publique.medicaments.gouv.fr/

For more information please ask your doctor.

sitavig02